Zivelonghi, Cecilia
Dinoto, Alessandro
Irani, Sarosh R.
McKeon, Andrew
Pilotto, Andrea
Padovani, Alessandro
Masciocchi, Stefano
Magni, Eugenio
Mancinelli, Chiara R.
Capra, Ruggero
Maniscalco, Giorgia T.
Volonghi, Irene
Easton, Ava
Alberti, Daniela
Zanusso, Gianluigi
Monaco, Salvatore
Salvagno, Gian Luca
Lippi, Giuseppe
Ferrari, Sergio
Mariotto, Sara http://orcid.org/0000-0002-7806-3103
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Received: 16 February 2023
Accepted: 18 April 2023
First Online: 12 May 2023
Declarations
:
: The local ethical committee approved the present study (Comitato Etico per la Sperimentazione Clinica, Azienda Ospedaliera Universitaria Integrata di Verona; BIOB-NEU-DNA-2014, protocol 13582).
: Patients gave her informed consent to participate.
: Patients gave her informed consent for publication.
: S Irani is a coapplicant and receives royalties on a licensed patent application WO/210/046716 (U.K. patent no., PCT/GB2009/051441) entitled “Neurological Autoimmune Disorders” and has filed “Diagnostic Strategy to improve specificity of CASPR2 antibody detection (PCT/G82019 /051257); he has received honoraria and research support from UCB, Immunovant, MedImmun, Roche, Cerebral therapeutics, ADC therapeutics, CSL Behring and ONO Pharma; A.McKeon has received royalties pertaining to the commercialization of septin-5 and MAP1B antibodies for diagnosis of autoimmune neurological diseases, has patents pending for neural IgGs as biomarkers for diagnosis and treatment of autoimmune neurological disorders, and has received research support from Euroimmun AG; APi served in the advisory board of Z-cube (technology division of Zambon pharmaceuticals), he received honoraria from Z-cube s.r.l., Biomarin, Zambon, Abbvie, Nutricia and Chiesi pharmaceuticals. He received research support from Vitaflo Germany and Zambon Italy; APa is consultant and served on the scientific advisory board of GE Healthcare, Eli-Lilly and Actelion Ltd Pharmaceuticals, received speaker honoraria from Nutricia, PIAM, Lansgstone Technology, GE Healthcare, Lilly, UCB Pharma and Chiesi Pharmaceuticals, he is funded by Grant of Ministry of University (MURST); the other authors report no disclosures relevant to the manuscript<b>.</b> S Mariotto is associate editor of Immunologic Research.